These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1756510)

  • 1. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
    Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Cancer Lett; 1991 Dec; 60(3):205-11. PubMed ID: 1756510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
    Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
    Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
    Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Cancer Lett; 1991 Jul; 59(1):45-50. PubMed ID: 1878860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).
    Lhoste EF; Roebuck BD; Longnecker DS
    Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking effects of synthetic trypsin inhibitor (camostat) on pancreatic carcinogenesis in hamsters initiated with N-nitrosobis(2-oxopropyl)amine.
    Furukawa F; Nishikawa A; Imazawa T; Yoshimura H; Sato M; Aze Y; Takahashi M
    Pancreas; 1994 Jan; 9(1):78-82. PubMed ID: 8108374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters.
    Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
    Carcinogenesis; 1990 Dec; 11(12):2223-6. PubMed ID: 2265473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C; Liddle RA; Williams JA; Grendell JH
    Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary linoleic acid on pancreatic carcinogenesis in rats and hamsters.
    Appel MJ; van Garderen-Hoetmer A; Woutersen RA
    Cancer Res; 1994 Apr; 54(8):2113-20. PubMed ID: 8174115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas.
    Wisner JR; McLaughlin RE; Rich KA; Ozawa S; Renner IG
    Gastroenterology; 1988 Jan; 94(1):109-13. PubMed ID: 3335282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of soybean trypsin inhibitor during initiation and promotion phases of N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis.
    Takahashi M; Imaida K; Furukawa F; Hayashi Y
    Prog Clin Biol Res; 1991; 369():145-54. PubMed ID: 1946514
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.
    Adler G; Reinshagen M; Koop I; Göke B; Schafmayer A; Rovati LC; Arnold R
    Gastroenterology; 1989 Apr; 96(4):1158-64. PubMed ID: 2647576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of crude soybean trypsin inhibitor on pancreatic ductal carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine.
    Furukawa F; Nishikawa A; Imaida K; Mitsui M; Enami T; Hayashi Y; Takahashi M
    Carcinogenesis; 1992 Nov; 13(11):2133-5. PubMed ID: 1330352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function.
    Niederau C; Lüthen R; Niederau M; Strohmeyer G; Ferrell LD; Grendell JH
    Digestion; 1990; 46 Suppl 2():217-25. PubMed ID: 2262055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model.
    Pour PM; Lawson T; Helgeson S; Donnelly T; Stepan K
    Carcinogenesis; 1988 Apr; 9(4):597-601. PubMed ID: 2833367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of green tea extract on the process of pancreatic carcinogenesis induced by N-nitrosobis-(2-oxypropyl)amine (BOP) and on tumor promotion after transplantation of N-nitrosobis-(2-hydroxypropyl)amine (BHP)-induced pancreatic cancer in Syrian hamsters.
    Hiura A; Tsutsumi M; Satake K
    Pancreas; 1997 Oct; 15(3):272-7. PubMed ID: 9336791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
    Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H
    Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic lesions induced by a single dose of N-nitrosobis(2-oxopropyl)amine and selection by resistance to cytotoxicity.
    Scarpelli DG; Subbarao V; Rao MS
    Toxicol Pathol; 1986; 14(3):324-30. PubMed ID: 3787114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of influence of low blood cholesterol levels on pancreatic carcinogenesis after initiation with N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters.
    Ogawa T; Makino T; Hirose N; Sugano M
    Carcinogenesis; 1994 Aug; 15(8):1663-6. PubMed ID: 8055648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
    Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
    Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.